Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (3289)	4/2/2001 11:31:57 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 52153

>> Do hostile takeovers happen much in biotech ? << Never. >> Might be a good time for the bigger fish to snap up some minnows - how much value is left if the employees walk though ? << MLNM gobbling TELK? 120%.

To: nigel bates who wrote (3289)	4/2/2001 11:34:51 AM
From: nigel bates	Read Replies (1) \| Respond to of 52153

Might be a good time for the bigger fish to snap up some minnows ...anyone got a list of biotechs under $250m cap with less than three quarters of burn left (and with a respectable pipeline or technology) ?

To: nigel bates who wrote (3289)	4/2/2001 11:40:42 AM
From: Jibacoa	Read Replies (1) \| Respond to of 52153

I will ask for Peter's indulgence and make a short comment on what some may consider a "penny stock", Anika Therapeutics.<g> biz.yahoo.com It sells for less than half of book and also a fraction of sales.<g> What brought my attention was its good up-move today: siliconinvestor.com And the fact that it seems to have a good amount of room "upstairs" to run.<g> siliconinvestor.com Also the fact that they don't seem to have any LTD.<g> Bernard